In conclusion, we found that knockout of CDR2L in an ovarian cancer line dysregulates genes involved in ribosome biogenesis, protein synthesis and cell cycle-related processes, ultimately impairing cell proliferation. Here, CDR2L is linked to ovarian carcinoma.